Associated Papers
Calreticulin Mutations in Bulgarian MPN Patients.
Pavlov I et al.
Pathology Oncology Research : Por, 2018
Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.
Kang MG et al.
Oncotarget, 2016
Clinical Manifestation of Calreticulin Gene Mutations in Essential Thrombocythemia without Janus Kinase 2 and MPL Mutations: A Chinese Cohort Clinical Study.
Sun C et al.
Chinese Medical Journal, 2016
Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.
Rashid M et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion, 2016
Coexisting JAK2V617F and CALR Exon 9 Mutations in Myeloproliferative Neoplasms - Do They Designate a New Subtype?
Ahmed RZ et al.
Asian Pacific Journal of Cancer Prevention : Apjcp, 2016
Calreticulin mutations in myeloproliferative neoplasms and new methodology for their detection and monitoring.
Chi J et al.
Annals of Hematology, 2015
Calreticulin mutations and long-term survival in essential thrombocythemia.
Tefferi A et al.
Leukemia, 2014
Clinical importance of different calreticulin gene mutation types in wild-type JAK2 essential thrombocythemia and myelofibrosis patients.
Qiao C et al.
Haematologica, 2014
Select a paper to view details